Federal Register / Vol. 87, No. 90 / Tuesday, May 10, 2022 / Notices 28013 

Matters to be Considered: The agenda 

will include discussions on (1) NIHfunded clinical trials; (2) domestic 

pediatric tuberculosis; (3) immigration 

and tuberculosis; and (4) considerations 

for bringing new tuberculosis drugs to 

market. Agenda items are subject to 

change as priorities dictate. 

Public Participation 

Written Public Comment: Members of 

the public are welcome to submit 

written comments in advance of the 

meeting. Written comments must be 

submitted by emailing nchhstppolicy@

cdc.gov with subject line ‘‘June ACET 

Public Comment Registration’’ by June 

7, 2022. 

Oral Public Comment: Individuals 

who would like to make an oral 

comment during the public comment 

period must register by emailing nchhst

ppolicy@cdc.gov with subject line ‘‘June 

ACET Public Comment Registration’’ by 

June 16, 2022. The public comment 

period is on June 22, 2022, at 11:55 a.m., 

EDT. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–09949 Filed 5–9–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2022–0062] 

Advisory Committee on Immunization 

Practices (ACIP) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting and request 

for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting of the Advisory 

Committee on Immunization Practices 

(ACIP). This meeting is open to the 

public. Time will be available for public 

comment. 

DATES: The meeting will be held on June 

22, 2022, from 10:00 a.m. to 5:00 p.m., 

EDT, and June 23, 2022, from 10:00 a.m. 

to 2:00 p.m., EDT (times subject to 

change). The meeting will be webcast 

live via the World Wide Web. Written 

comments must be received on or before 

June 23, 2022. 

ADDRESSES: You may submit comments 

identified by Docket No. CDC–2022– 

0062 by either of the following methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

Mailstop H24–8, Atlanta, Georgia 

30329–4027, Attn: ACIP Meeting. 

Instructions: All submissions received 

must include the Agency name and 

Docket Number. All relevant comments 

received in conformance with the 

https://www.regulations.gov suitability 

policy will be posted without change to 

https://www.regulations.gov, including 

any personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

https://www.regulations.gov. Do not 

submit comments by email; CDC does 

not accept comments by email. Written 

public comments submitted by 72 hours 

prior to the ACIP meeting will be 

provided to ACIP members before the 

meeting. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, Centers for 

Disease Control and Prevention, 

National Center for Immunization and 

Respiratory Diseases, 1600 Clifton Road 

NE, Mailstop H24–8, Atlanta, Georgia 

30329–4027, Telephone: (404) 639– 

8367; Email: ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

use of immunizing agents. In addition, 

under 42 U.S.C. 1396s, the committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children (VFC) program, 

along with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under provisions of the Affordable Care 

Act, section 2713 of the Public Health 

Service Act, immunization 

recommendations of the ACIP that have 

been approved by the CDC Director and 

appear on CDC immunization schedules 

must be covered by applicable health 

plans. 

Matters to be considered: The agenda 

will include discussions on influenza 

vaccines; pneumococcal vaccine; 

human papillomavirus vaccine; 

measles, mumps, rubella (MMR) 

vaccine; respiratory syncytial virus 

vaccine; rotavirus vaccine; and 

Chikungunya vaccine. Recommendation 

votes on influenza vaccines, 

pneumococcal vaccine, and MMR 

vaccine are scheduled. No VFC votes are 

scheduled. Agenda items are subject to 

change as priorities dictate. For more 

information on the meeting agenda, visit 

https://www.cdc.gov/vaccines/acip/ 

meetings/index.html. The meeting will 

be webcast live via the World Wide 

Web; for more information on ACIP, 

visit the ACIP website: https:// 

www.cdc.gov/vaccines/acip/index.html. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 

posted on https://www.regulations.gov. 

Therefore, do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

Written Public Comment: The docket 

will be opened to receive written 

comments on May 10, 2022. Written 

comments must be received on or before 

June 23, 2022. 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. Oral 

public comment will occur before any 

scheduled votes, including all votes 

relevant to the ACIP’s Affordable Care 

Act and Vaccines for Children program 

roles. Priority will be given to 

individuals who submit a request to 

make an oral public comment before the 

meeting according to the procedures 

below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the June 22–23, 


lotter on DSK11XQN23PROD with NOTICES1
28014 Federal Register / Vol. 87, No. 90 / Tuesday, May 10, 2022 / Notices 

2022, ACIP meeting must submit a 

request at https://www.cdc.gov/ 

vaccines/acip/meetings/index.html no 

later than 11:59 p.m., EDT, June 13, 

2022, according to the instructions 

provided. 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

by June 15, 2022. To accommodate the 

significant interest in participation in 

the oral public comment session of 

ACIP meetings, each speaker will be 

limited to 3 minutes, and each speaker 

may speak only once per meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–09950 Filed 5–9–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—SIP22–005, 

Building Resilience Against Climate 

Effects (BRACE): Enhancing Practical 

Guidance To Support Climate and 

Health Adaptation Planning; Amended 

Notice of Closed Meeting 

Notice is hereby given of a change in 

the meeting of the Disease, Disability, 

and Injury Prevention and Control 

Special Emphasis Panel (SEP)—SIP22– 

005, Building Resilience Against 

Climate Effects (BRACE): Enhancing 

Practical Guidance to Support Climate 

and Health Adaptation Planning; May 4, 

2022, 11 a.m.–6 p.m., EDT, in the 

original FRN. 

The meeting was published in the 

Federal Register on March 1, 2022, 

Volume 87, Number 40, page 11444. 

The meeting is being amended to 

change the meeting date and time and 

should read as follows: 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

SIP22–005, Building Resilience Against 

Climate Effects (BRACE): Enhancing 

Practical Guidance to Support Climate 

and Health Adaptation Planning. 

Date: May 19, 2022. 

Time: 3 p.m.–6 p.m., EDT. 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

The meeting is closed to the public. 

SUPPLEMENTARY INFORMATION: In 

accordance with 41 CFR 102–3.150(b), 

less than 15 calendar days’ notice is 

being given for this amended closed 

meeting due to an unforeseen medical 

emergency and exceptional 

circumstances that led to an anomaly of 

programmatic matters and the necessity 

to resolve issues, reschedule, and 

convene as soon as possible. 

FOR FURTHER INFORMATION CONTACT: Jaya 

Raman, Ph.D., Scientific Review Officer, 

CDC, 4770 Buford Highway, Mailstop 

F80, Atlanta, Georgia 30341, Telephone: 

(770) 488–6511, kva5@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–10023 Filed 5–9–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers CMS–10286 & CMS– 

10630] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by June 9, 2022. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at: 

https://www.cms.gov/Regulations-andGuidance/Legislation/Paperwork

ReductionActof1995/PRA-Listing.html. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 


lotter on DSK11XQN23PROD with NOTICES1